PCM
REGN icon

Palisade Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Palisade Capital Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-578
Closed -$323K – 411
2021
Q2 		$323K Sell
578
-700
-55% -$355K 0.01% 375
2021
Q1 		$605K Sell
1,278
-25
-2% -$12.2K 0.01% 324
2020
Q4 		$629K Buy
1,303
+125
+11% +$67.5K 0.02% 324
2020
Q3 		$659K Buy
+1,178
New +$714K 0.02% 323
2020
Q2 		– Sell
-1,378
Closed -$673K – 408
2020
Q1 		$673K Buy
+1,378
New +$568K 0.02% 336

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return